SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-21-000045
Filing Date
2021-11-09
Accepted
2021-11-09 16:06:35
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20210930.htm   iXBRL 10-Q 1728080
2 EX-31.1 kronq3fy2021ex311.htm EX-31.1 18567
3 EX-31.2 kronq3fy2021ex312.htm EX-31.2 18532
4 EX-32.1 kronq3fy2021ex321.htm EX-32.1 11502
10 kron-20210930_g1.jpg GRAPHIC 135831
  Complete submission text file 0001741830-21-000045.txt   7148642

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20210930.xsd EX-101.SCH 42520
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20210930_cal.xml EX-101.CAL 74831
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20210930_def.xml EX-101.DEF 178581
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20210930_lab.xml EX-101.LAB 537280
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20210930_pre.xml EX-101.PRE 348542
11 EXTRACTED XBRL INSTANCE DOCUMENT kron-20210930_htm.xml XML 1141621
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 211392096
SIC: 2834 Pharmaceutical Preparations